3.99
前日終値:
$3.66
開ける:
$3.51
24時間の取引高:
4.17M
Relative Volume:
0.85
時価総額:
$948.85M
収益:
-
当期純損益:
$-252.18M
株価収益率:
-3.7642
EPS:
-1.06
ネットキャッシュフロー:
$-185.29M
1週間 パフォーマンス:
-2.44%
1か月 パフォーマンス:
-10.34%
6か月 パフォーマンス:
+124.16%
1年 パフォーマンス:
+54.05%
Sana Biotechnology Inc Stock (SANA) Company Profile
名前
Sana Biotechnology Inc
セクター
電話
(206) 701-7914
住所
188 EAST BLAINE STREET, SUITE 400, SEATTLE
SANA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
SANA
Sana Biotechnology Inc
|
3.99 | 974.90M | 0 | -252.18M | -185.29M | -1.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
437.15 | 110.25B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
693.50 | 73.04B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
449.16 | 59.98B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
907.98 | 54.90B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.22 | 40.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sana Biotechnology Inc Stock (SANA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-24 | 開始されました | Wedbush | Outperform |
| 2025-07-03 | 再開されました | Morgan Stanley | Overweight |
| 2025-03-18 | アップグレード | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-14 | 開始されました | Jefferies | Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2024-11-05 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-06-26 | 開始されました | Rodman & Renshaw | Buy |
| 2024-01-16 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2023-09-25 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-09-05 | 開始されました | Citigroup | Buy |
| 2023-08-14 | 開始されました | TD Cowen | Market Perform |
| 2023-05-02 | 開始されました | H.C. Wainwright | Neutral |
| 2021-03-01 | 開始されました | BofA Securities | Buy |
| 2021-03-01 | 開始されました | Goldman | Neutral |
| 2021-03-01 | 開始されました | JP Morgan | Neutral |
| 2021-03-01 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Sana Biotechnology Inc (SANA) 最新ニュース
Will Sana Biotechnology Inc. stock benefit from automation2025 Institutional Moves & Consistent Growth Stock Picks - newser.com
Is Sana Biotechnology's (SANA) Ongoing Loss Reduction Shaping Its Long-Term Investment Narrative? - simplywall.st
Custom strategy builders for tracking Sana Biotechnology Inc.Gap Up & Safe Capital Allocation Plans - newser.com
How Sana Biotechnology Inc. stock benefits from global expansionQuarterly Portfolio Report & Reliable Price Breakout Alerts - newser.com
Evaluating Sana Biotechnology Inc. with trendline analysisPortfolio Performance Summary & High Accuracy Buy Signal Tips - newser.com
Is Sana Biotechnology Inc. stock a smart buy before Fed meetingPortfolio Gains Summary & Risk Controlled Daily Plans - Fundação Cultural do Pará
Why Sana Biotechnology Inc. stock is a must watch in 2025Product Launch & Weekly Stock Breakout Alerts - Fundação Cultural do Pará
Visual trend scoring systems applied to Sana Biotechnology Inc.2025 Institutional Moves & Growth Focused Entry Point Reports - newser.com
Identifying reversal signals in Sana Biotechnology Inc.Market Growth Summary & Stock Portfolio Risk Control - newser.com
What MACD signals say about Sana Biotechnology Inc.July 2025 Institutional & Accurate Technical Buy Alerts - newser.com
Long term hold vs stop loss in Sana Biotechnology Inc.Earnings Growth Summary & Stock Portfolio Risk Control - newser.com
Using economic indicators to assess Sana Biotechnology Inc. potentialJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - newser.com
All You Need to Know About Sana (SANA) Rating Upgrade to Buy - sharewise.com
Can Sana Biotechnology Inc. recover in the next quarterMarket Movement Recap & Long Hold Capital Preservation Plans - newser.com
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Zymeworks (ZYME), Sana Biotechnology (SANA) and Nektar Therapeutics (NKTR) - The Globe and Mail
Will Sana Biotechnology Inc. stock maintain momentum in 20252025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
Applying big data sentiment scoring on Sana Biotechnology Inc.2025 Technical Patterns & Weekly Momentum Picks - newser.com
Assessing Sana Biotechnology’s (SANA) Valuation After Strategic Refocus and Encouraging Clinical Updates - Yahoo Finance
Will Sana Biotechnology’s (SANA) Sharper Focus on Diabetes and CAR T Unlock Its Next Chapter? - Sahm
HC Wainwright & Co. Maintains Sana Biotechnology (SANA) Buy Recommendation - Nasdaq
Sana: Q3 Earnings Snapshot - theheraldreview.com
Sana Biotechnology Makes Bold Bet On Diabetes And Gene Therapy - Finimize
Sana Biotechnology Reports Reduced Losses and Strong Liquidity - TipRanks
Decoding Sana Biotechnology Inc (SANA): A Strategic SWOT Insight - GuruFocus
Sana Biotechnology Inc (SANA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):